# Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension

> **NCT05165251** · PHASE4 · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 480 (estimated)

## Conditions studied

- Isolated Systolic Hypertension

## Interventions

- **DRUG:** Amlodipine/Atorvastatin 5 Mg-10 Mg ORAL TABLET
- **DRUG:** Amlodipine 5mg
- **OTHER:** Lifestyle intervention

## Key facts

- **NCT ID:** NCT05165251
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-04
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-01
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05165251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05165251, "Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05165251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*